Please login to the form below

Not currently logged in
Email:
Password:

Bayer wins FDA approval for MS electronic autoinjector and app

US regulator gives green light to Betaconnect and myBETA app

Bayer

The FDA has approved Bayer’s electronic autoinjector Betaconnect and associated myBETA app for multiple sclerosis patients to use.

The app - created by Medicom Innovation Partner - uses Bluetooth technology to connect with the autoinjector that administers Betaseron (interferon beta-1b), so patients can access and share their data with healthcare professionals via a mobile phone or computer.

“Since introducing the first FDA approved treatment option for relapsing remitting multiple sclerosis patients more than two decades ago, we’ve listened closely to the community to understand their needs and how we can support them,” said Mark Rametta, Bayer’s medical director for Neurology.

The app and the Betaconnect navigator also includes around-the-clock access to nurse support.

Patients using other injection methods to take Betaseron can also manually enter injection information into the app and can participate in sharing their data with their healthcare team.

The myBETA app will be available for free download at the Apple store, Google Play or Betaseron.com in mid-July.

Article by
Gemma Jones

19th June 2017

From: Marketing, Regulatory

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
EY Life Sciences

Our global reach Against a backdrop of regulatory, digital, financial and global transformation, Life Sciences companies are finding integration and...

Latest intelligence

OUTiCO Case Study - Product Launch
POSITIVE FORMULARY SUCCESS WITHIN 8 MONTHS!...
An insight into Multi-Channel Account Management
At OUTiCO we often talk about moving away from traditional methods, embracing change, and offering an exceptional outsourcing service, but what does that mean day to day?...
14_ipad_lowres.jpg
Why AI might be the rep’s best friend
When looking for the next big thing in digital communication, there’s nothing bigger than the sweeping changes promised by artificial intelligence. There’s little doubt that AI is coming to pharma...

Infographics